Hussman Strategic Advisors, Inc. Axogen, Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $384 Million
- Q1 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 63,000 shares of AXGN stock, worth $688,590. This represents 0.3% of its overall portfolio holdings.
Number of Shares
63,000
Previous 31,500
100.0%
Holding current value
$688,590
Previous $519,000
124.47%
% of portfolio
0.3%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding AXGN
# of Institutions
191Shares Held
39.2MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$48.9 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$35.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$28.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$27.7 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$17.4 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $462M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...